New Data on Efficacy and Cardiovascular Safety
One of the most controversial questions in cardiovascular pharmacology is whether testosterone replacement therapy is safe for the cardiovascular system, especially in elderly men. There is little debate that as men age, their testosterone levels fall and low testosterone levels have an association with more atherosclerosis, coronary artery disease, and heart failure. A key debated question is whether the administration of exogenous testosterone to increase testosterone levels back to normal alters the incidence of adverse cardiovascular events. In recent papers in the Journal of the American Heart Association,1,2Journal of the American College of Cardiology,3 and Sexual Medicine Reviews,4 my colleagues and I have reviewed the numerous studies on this subject. This literature presents some of the most controversial group of papers that I have reviewed, with some studies suggesting that testosterone use is associated with an increase in adverse cardiac events including major adverse cardiac events (cardiovascular death, myocardial infarction, stroke), whereas others suggest just the opposite. The problem is that many of these studies are observational, the testosterone preparations vary, not all studies have followed up the testosterone levels once therapy is started, some studies included soft end points to describe the adverse cardiac events, the cardiac events were not prespecified as the primary outcome, the duration of follow-up was short, the baseline characteristics of the patients were very heterogeneous with varying degrees of underlying risk factors, and other issues that we have described. The only way this issue will ever truly be resolved is for a large prospective, randomized, blinded, long-term study to be carried out with major adverse cardiac events as the primary end point. It is my understanding that an industry consortium is developing such a protocol. However, it will be many years before data are available. In the meantime, the Food and Drug Administration has released new restrictions on the labeling for testosterone replacement therapy, as recently described.3
Although testosterone is known to be effective in patients with primary hypogonadism, the significance of the low testosterone associated with aging has been debated. There are mixed data suggesting that in these types of patients, testosterone replacement may improve sexual functioning (improved libido and erectile function), improve muscle mass, decrease fat mass, improve muscle strength, and perhaps improve mood and energy level.
The Testosterone Trials, sponsored by the National Institutes of Health, were conducted to help clarify the confusing literature on testosterone replacement therapy, and the data from these clinical trials are now emerging.5 These studies may answer some of the unresolved issues surrounding testosterone replacement therapy. They consist of 7 double-blinded, Placebo-controlled, interlinked multicenter studies in which men who were 65 years and older with serum testosterone levels that averaged <275 ng/dL were randomized to testosterone gel versus placebo gel for 1 year, with efficacy assessment at baseline and then every 3 months for 1 year. Results from 3 of these trials were recently reported. To be eligible for the Sexual Function Trial, men had to report decreased libido on questionnaires; to be eligible for the Physical Function Trial, men had to report difficulties walking or climbing stairs; and to be eligible for the Vitality Trial, men had to report low vitality on a questionnaire. The preparation of testosterone used was AndroGel at 5 g daily. Serum concentrations of testosterone were measured throughout the study. The primary outcome for the Sexual Function Trial was change from baseline on a questionnaire regarding sexual activity; secondary outcomes were changes in score in erectile function and sexual desire domains. For the Physical Function Trial, the primary outcome was percentage of men who improved their 6-minute walk tests by at least 50 m, and the secondary outcome was percentage of men who improved their physical function domain on a questionnaire. For the Vitality Trial, the primary outcome was percentage of men who improved their score for fatigue on a questionnaire by more than 4 points, and secondary outcomes were other improvements from baseline in questionnaires dealing with fatigue and depression. In addition, the patients were asked every 3 months about their own impressions regarding changes in sexual desire, ability to walk, and level of vitality. In the February 18, 2016 issue of the New England Journal of medicine, the first outcome paper from the Testosterone Trials Investigators was published by Snyder et al,5 which has provided important new information on the efficacy and safety of testosterone in 790 older men who participated in 1 of the 3 main Testosterone Trials as described above. Of note, at baseline, many of the men were obese, had hypertension, and 14.7% had histories of myocardial infarctions. The testosterone treatments did increase testosterone concentrations to the normal range for younger men. As determined by the Psychosexual Daily Questionnaire, question number 4, testosterone replacement therapy significantly increased sexual activity, and it also improved libido and erectile function. In the Physical Function Trial, men who took testosterone did not significantly increase their 6-minute walk time by at least 50 m. However, when combining men who participated in all 3 of the trials, testosterone replacement therapy was associated with a significant increase in the percentage of men who achieved an increase in their 6-minute walk times by at least 50 m (20.5% vs 12.6%; P = .003). The primary end point of an improvement in vitality on a questionnaire by more than 4 points was not achieved in the Vitality Trial; but when combining all 3 trials, testosterone was associated with an increase in score for vitality compared to baseline. Men on testosterone reported slightly better moods and less depression than those on placebo.
Importantly and in contrast to some of the recent reports that have caused concern about the use of testosterone,68 there was no signal for an increase in adverse cardiovascular events in the testosterone group. There was 1 myocardial infarction in the placebo group and 2 in the testosterone group; there were 5 strokes in each group; and there was 1 death from cardiovascular causes in the placebo group and 0 in the testosterone group. In total, there were 7 patients in the placebo group and 7 patients in the testosterone group who had a myocardial infarction, stroke, or death from cardiovascular causes. There were 7 deaths from any cause in the placebo group and 3 in the testosterone group. Although more men in the testosterone group had a prostate-specific antigen level of 1.0 ng/ml or higher during the study, only 1 participant, who was in the testosterone group, was diagnosed with prostate cancer during therapy; 3 more developed it during the following year (2 in the testosterone group and 1 in the placebo group). As expected and as seen in many other studies, the use of testosterone was associated with a hemoglobin level of 17.5 g/dL or more in 7 men but none in the placebo group. Although the authors conclude that the number of patients in the study was too low to draw conclusions about the risk of testosterone replacement therapy, it is at least reassuring that no signal for an increase in adverse cardiovascular events was detected. However, larger studies will be needed to definitively rule out any adverse effects of testosterone on the cardiovascular system. It is likely that additional safety data will emerge from the Testosterone Trials Investigators studies. These investigators are to be congratulated on a study that uses a well-designed systematic approach to assess and show the effectiveness of testosterone replacement therapy on multiple domains in a well-defined patient population. Hopefully, this will be one of several reports from this important group of studies, which helps to clarify the therapeutic role of testosterone replacement therapy.
Declaration of Conflicting Interests The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Dr Kloner is a consultant to Abbvie, TesoRx, and Lipocine.
Funding The author(s) received no financial support for the research, authorship, and/or publication of this article.
Read more:
Testosterone Replacement Therapy - cpt.sagepub.com
Contact Us Now
- Behavioral and Health Changes Decrease Levels of Testosterone - January 5th, 2021
- Testosterone Replacement Therapy Might Be Legal, but It's Still Cheating in Professional Sports - November 15th, 2020
- Testosterone Replacement - Video - October 26th, 2020
- Ensuring The Safety of Testosterone Replacement Therapy for Men - October 18th, 2020
- Testosterone Creams for Low Testosterone Treatment and Andropause - August 10th, 2020
- The History, Myths and Misconceptions of Testosterone - May 13th, 2020
- Is Testosterone Good or Bad for Your Heart? Or is Estradiol the Real Culprit? - May 7th, 2020
- The Dangerous Hyperbole Surrounding Testosterone Replacement Therapy - July 16th, 2019
- Can men have hot flashes? - July 6th, 2019
- Safety of Testosterone Replacement Therapy | The Medical ... - June 29th, 2016
- Testosterone Replacement Therapy Resources - Fabulously ... - June 15th, 2016
- Prostate cancer: Testosterone therapy 'does not increase aggressive ... - May 11th, 2016
- Testosterone Replacement Therapy | Low Testosterone | Low T - April 28th, 2016
- Low Testosterone, Low T, E.D. | Andrologix.com - April 21st, 2016
- Low Testosterone Treatments - Testosterone Replacement Therapy - April 21st, 2016
- Testosterone Therapy Side Effects - DrugWatch - April 10th, 2016
- Side Effects of Testosterone Replacement Therapy (TRT) - April 10th, 2016
- Testosterone Replacement Therapy: Myths and Facts - April 5th, 2016
- Testosterone Replacement Therapy - Bottar Leone, PLLC - February 8th, 2016
- Heart Attack Risk from Testosterone Replacement Therapy - February 8th, 2016
- Book - What You Need to Know About Low Testosterone - February 8th, 2016
- Testosterone Replacement Therapy in Torrance, CA - November 2nd, 2015
- Male Hormone Replacement | Low Testosterone Treatment - August 19th, 2015
- Hormone & Testosterone Replacement Therapy - August 15th, 2015
- testosterone replacement therapy cost , low testosterone therapy , buy testosterone online - Video - May 5th, 2015
- natural testosterone supplement , natural testosterone , natural testosterone replacement therapy - Video - May 3rd, 2015
- Greater Than 40 Fitness Testosterone Replacement Therapy Update - Video - April 17th, 2015
- Testosterone therapy: Potential benefits and risks as you ... - April 13th, 2015
- Testosterone Replacement Therapy - Risk Myths - Video - April 11th, 2015
- Does Testosterone Replacement Therapy Increase the Risk of Prostate Cancer? - Video - April 11th, 2015
- ALC - Testosterone Replacement Therapy - Video - April 11th, 2015
- TRT - 6 Week Update / Beware Arimidex! (Testosterone Replacement Therapy) - Video - April 9th, 2015
- TRT - 1 Month Bloodwork Results / Protocol Adjustment (Testosterone Replacement Therapy) - Video - March 29th, 2015
- Testosterone Replacement Therapy Final - Video - March 21st, 2015
- Testosterone Replacement Therapy - Dr. G - Video - March 19th, 2015
- Living Well: Testosterone therapy good idea or not? - March 14th, 2015
- New studies fail to find cardiovascular risk with testosterone therapy - March 10th, 2015
- Testosterone Replacement Therapy for Men | AAG Health Gains - March 9th, 2015
- AM I HIDING SOMETHING? Where's My Blood work? | TRT Update - Video - March 6th, 2015
- Andropause and Testosterone Replacement Therapy - Video - March 5th, 2015
- Treat Low T Symptoms w/ Testosterone Replacement Therapy - February 23rd, 2015
- The LIFE*MOD Podcast With Dr. Gonzalez - Testosterone Replacement Therapy Part 1 - Video - February 12th, 2015
- Is testosterone replacement therapy safe? Take a look at ... - February 7th, 2015
- Introduction to Testosterone Replacement Therapy (TRT) - Video - February 1st, 2015
- what is testosterone replacement therapy | Find what is testosterone replacement therapy - Video - January 31st, 2015
- From Wellness and Prevention to Testosterone Replacement Therapy - Video - January 31st, 2015
- Testicular cancer - Testosterone replacement therapy - yourprivates.org.uk - Video - January 31st, 2015
- Testosterone Replacement Therapy testimonial - Dr. Retzler Portland Oregon - Video - December 25th, 2014
- Dr. Allens Device Boost Mens Wellbeing by Treating Enlarged Prostate & Chronic Prostatitis, While Testosterone ... - December 10th, 2014
- Carey Danis & Lowe Weighs in on Testosterone Gel Safety - November 26th, 2014
- Testosterone Replacement Therapy (TRT) - Danger & Play - November 7th, 2014
- Testosterone Replacement Therapy for Women | eHow - November 4th, 2014
- Testosterone Replacement Therapy For Young Men - Thumotic - October 30th, 2014
- Lipocine Announces Positive Top-line Results From Phase 2a Study Of LPCN 1111 - October 13th, 2014
- Cleveland Clinic: Testosterone Replacement Therapy - October 1st, 2014
- Strict Limitations May Be Coming for Low Testosterone Treatment - October 1st, 2014
- Testosterone Replacement Therapy (TRT) Update - New Test Results - Video - September 28th, 2014
- It's Time To Cross The T's... - September 19th, 2014
- Endocrine Society Tells FDA Testosterone Therapy Should Only Be for Men with Hypogonadism - September 18th, 2014
- Warning over risks associated with testosterone replacement therapy - August 15th, 2014
- Is testosterone replacement therapy right for you? | Fox News - August 7th, 2014
- Do you need low T therapy? - August 7th, 2014
- Testosterone replacement therapy |Mens Medical New York PC ... - July 9th, 2014
- Low sex drive - or erectile dysfunction? - June 25th, 2014
- 1513 Hormone Replacement Therapy for Men - Video - June 13th, 2014
- Seen At 11: Testosterone Replacement Therapy Could Come With Serious Side Effects - Video - May 11th, 2014
- Are Low-T Drugs Putting Patients At High Risk? - May 10th, 2014
- Seen At 11: Experts Urge Caution When Using Popular Hormone Replacement Therapy - May 10th, 2014
- Viewer Mail - Testosterone Replacement Therapy/TRT Not Natty, Balls Busted, etc. - Video - May 4th, 2014
- NJ-Based Law Firm Exploring Potential Legal Claims from Side Effects of Testosterone Replacement Therapy - May 1st, 2014
- Testosterone Replacement Therapy in Men - myVMC - April 30th, 2014
- Acrux falls 15% on sales warning - April 28th, 2014
- Low Testosterone Claims: Options in a Growing Class Action Suit - Video - April 26th, 2014
- Reclaim Your Energy and Sex Drive | Testosterone ... - April 14th, 2014
- Testosterone Replacement Therapy - Video - April 12th, 2014
- FGSW - Weekly Weigh In & Update 15: Still Working On Mobility 03.31.14 - Video - April 7th, 2014
- FGSW Weekly Weigh In & Update 15 Still Working On Mobility 03 31 14 - Video - April 5th, 2014
- Discover the risk of prostate cancer with testosterone replacement therapy - Video - April 5th, 2014
- FGSW - Testosterone Replacement Therapy Update 03.27.14: An Improvement?? - Video - April 2nd, 2014
- Drug Recall Attorney at Herrera Law Firm, Inc., Comments on Reported Link Between Testosterone Drugs and Heart Attack ... - April 2nd, 2014
Word Count: 450